CN108079363A - A kind of kit and its application that cell processing is taken off for animal tissue - Google Patents
A kind of kit and its application that cell processing is taken off for animal tissue Download PDFInfo
- Publication number
- CN108079363A CN108079363A CN201711409636.1A CN201711409636A CN108079363A CN 108079363 A CN108079363 A CN 108079363A CN 201711409636 A CN201711409636 A CN 201711409636A CN 108079363 A CN108079363 A CN 108079363A
- Authority
- CN
- China
- Prior art keywords
- cell
- animal tissue
- acid
- liquid
- cell liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
- A61L15/325—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/64—Use of materials characterised by their function or physical properties specially adapted to be resorbable inside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
Abstract
The present invention relates to a kind of kit and its applications that cell processing is taken off for animal tissue.The kit that the present invention takes off cell processing for animal tissue includes at least one of de-cell liquid A, de-cell liquid B；Solute in the de-cell liquid A is at least one of sodium carbonate, potassium carbonate, EDTA trisodiums, tetra- sodium of EDTA, sodium phosphate, potassium phosphate；The de-cell liquid B is made of acid solution and salting liquid, and the acid in the acid solution is at least one of HCl, phosphoric acid, sulfuric acid, acetic acid, lactic acid, Glycolic acid, oxalic acid；Salt in the salting liquid is at least one of sodium chloride, potassium chloride, sodium sulphate, potassium sulfate.It is easy to operate when carrying out de- cell processing to animal tissue using kit of the present invention, it is at low cost, and cell and DNA are remained the bottom of compared in obtained product；And de- cell degree is higher, products obtained therefrom eliminates main immunogenic ingredient, and good biocompatibility, immunogenicity is low, can preferable regulating cell stick, migrate, be proliferated and break up.
Description
Technical field
The present invention relates to a kind of kit and its applications, and in particular to a kind of reagent that cell processing is taken off for animal tissue
Box and its application.
Background technology
The method that current most common method for removing cells is physics and chemical treatment is combined, including with stirring or ultrasound
Ripple, mechanical massage or pressurization are freezed and thaw to destroy cell membrane, release cell component, so more conducively subsequent
The de- cell cleaning of chemical detergent.Physical method is generally inadequate to realize that in itself completely de- cell, chemical method are more
Using zymetology processing method, such as some trypsase, enzyme process is during cell free, it is also possible to decompose some albumen
Matter has a certain impact to the ingredient of itself.These methods can be different degrees of influence change histoorgan matrix biopolymers chemistry
Constituent, complicated for operation, cost is higher and de- cell degree is relatively low, tends to have cell residue.
The content of the invention
One kind is provided and is taken off carefully for animal tissue it is an object of the invention to overcome above-mentioned the deficiencies in the prior art part
The novel agent box of born of the same parents' processing, when taking off cell processing to animal tissue using the kit, de- cell degree is higher, obtained product
Middle cell and DNA residuals are the bottom of compared with.
Meanwhile application and use the present invention also provides mentioned reagent box in cell processing is taken off for animal tissue
Mentioned reagent box carries out the method that animal tissue takes off cell processing.
To achieve the above object, the technical solution taken of the present invention is：A kind of examination that cell processing is taken off for animal tissue
Agent box, including de-cell liquid A and de-cell liquid B；Solute in the de-cell liquid A is sodium carbonate, potassium carbonate, EDTA tri-
At least one of sodium, tetra- sodium of EDTA, sodium phosphate, potassium phosphate；The de-cell liquid B is made of acid solution and salting liquid, described
Acid in acid solution is at least one of HCl, phosphoric acid, sulfuric acid, acetic acid, lactic acid, Glycolic acid, oxalic acid；In the salting liquid
Salt is at least one of sodium chloride, potassium chloride, sodium sulphate, potassium sulfate.
It is easy to operate when carrying out de- cell processing to animal tissue using kit of the present invention, it is at low cost, and obtain
Product in cell and DNA remain the bottom of compared with；And de- cell degree is higher, products obtained therefrom eliminates main immunogenic ingredient, raw
Object compatibility is good, and immunogenicity is low, and the preferable regulating cell of energy sticks, migrates, is proliferated and breaks up.
As the preferred embodiment of the kit of the present invention that cell processing is taken off for animal tissue, the de- cell
Solute in liquid A is made of (a) sodium carbonate and (b) EDTA trisodiums or tetra- salt of EDTA；In the de-cell liquid B, in acid solution
Acid is hydrochloric acid, and in sodium chloride or the de-cell liquid B, the acid in acid solution is Glycolic acid and HCl for salt in salting liquid,
Salt in salting liquid is sodium sulphate and sodium chloride.It is good and at low cost that sodium carbonate takes off cell effect, and it is thorough that hydrochloric acid takes off cell, to cell
Lethality it is big；Sodium chloride is neutral salt, not damaged to active ingredients such as collagens, at low cost, is easily obtained.
As the preferred embodiment of the kit of the present invention that cell processing is taken off for animal tissue, the de- cell
In liquid A, the mass fraction of solute is 2~10%；In the de-cell liquid B, sour concentration be 0.8~2mol/L, the concentration of salt
For 0.8~4mol/L.
The preferred embodiment of preparation method as Matrigel raw material of the present invention, the de-cell liquid A by
The component composition of following mass percents：(a) sodium carbonate 5% and tetra- sodium 0.01%-1% of (b) EDTA trisodiums or EDTA；It is described
De-cell liquid B is made of the component of following concentration：Hydrochloric acid 1mol/L and sodium chloride 1mol/L.Using the de-cell liquid of the concentration
A and de-cell liquid B can make de- cell most clean and complete on the premise of destruction active ingredient is reduced to the greatest extent.Using described dense
The de-cell liquid A of degree and de-cell liquid B can make de- cell most clean and complete on the premise of destruction active ingredient is reduced to the greatest extent
Entirely.
The more preferable embodiment of preparation method as Matrigel raw material of the present invention, the de-cell liquid A
In, the mass percent of component (b) is 0.1%
As the preferred embodiment of the kit of the present invention that cell processing is taken off for animal tissue, the de- cell
The pH value of liquid A is 7.2-7.4.
In addition, the application the present invention also provides mentioned reagent box in cell processing is taken off for animal tissue.
As the preferred embodiment of application of the present invention, the animal tissue is small intestine, nerve, bladder, skin, the heart
Bag or kidney etc.；The animal tissue is from pig, ox or sheep etc..In the present invention, animal tissue includes but not limited to small intestine, god
Through, bladder, skin, pericardium or kidney；The source of animal tissue includes but not limited to pig, ox or sheep.
Finally, the present invention also provides it is a kind of using mentioned reagent box carry out animal tissue take off cell processing method,
Comprise the following steps：
(1) animal tissue is taken, is sterilized after being cleaned；
(2) animal tissue after cleaning step (1) sterilizing, then carried out using de-cell liquid A to animal tissue at de- cell
Reason；
(3) animal tissue obtained after cell processing is taken off to step (2) using de-cell liquid B and carries out de- cell processing；
(4) step (3) is taken off cell processing gained animal tissue to be placed in PBS buffer solution or water for injection, is cleaned
Processing；
(5) step (4) cleaned animal tissue is freezed and shaped, obtain Matrigel raw material.
There is good biological effectiveness using Matrigel raw material made from the above method of the present invention, with surrounding group
It knits with good biocompatibility, basilar memebrane nutrition can be supplemented, improve epidermal growth microenvironment, enhance new old generation
It thanks, activation has immunocompetent Langerhans cell, induces immune system and maintenance function, forms net structure, locks water
Point, it is absorbed by the skin, plays the role of natural moisturizing factor；It can also promote to absorb, and moisten and form layer protecting film, make flesh
Skin more moisturizing is soft and smooth, strengthens the collagen activity in skin, keeps the integrality of cuticula moisture and fibre structure.
In addition, Matrigel raw material energy wound repairing produced by the present invention, is used especially for chronic wounds reparation.
The preferred embodiment of the method for cell processing is taken off as animal tissue of the present invention, in the step (2),
The volume ratio of de-cell liquid A and animal tissue is 4~30:1, using de-cell liquid A impregnate animal tissue 8~24 it is small when；It is described
In step (3), the volume ratio of de-cell liquid B and animal tissue is 4~30:1, animal tissue 8~24 is impregnated using de-cell liquid B
Hour.
The more preferable embodiment of the method for cell processing, the step (2) are taken off as animal tissue of the present invention
In, the volume ratio of de-cell liquid A and animal tissue is 5:1；In the step (3), the volume of de-cell liquid B and animal tissue
Than for 5:1.
The preferred embodiment of the method for cell processing is taken off as animal tissue of the present invention, the animal tissue is small
Intestines, nerve, bladder, skin, pericardium or kidney；The animal tissue derives from pig, ox or sheep.
The preferred embodiment of the method for cell processing is taken off as animal tissue of the present invention, in the step (1),
It is sterilized using disinfectant, the disinfectant contains Peracetic acid, hydrogen peroxide or ethanol solution；In the disinfectant, mistake
The volumn concentration of fluoroacetic acid is 0.05-1%；The volumn concentration of hydrogen peroxide is 0.5-10%；The volume hundred of ethyl alcohol
It is 5-30% to divide content；It in the step (2), is cleaned using cleaning solution, the cleaning solution is PBS solution or injection
Water, the pH value of the PBS solution is 7.0-7.4.
The preferred embodiment of cell processing, in the disinfectant, Peracetic acid are taken off as animal tissue of the present invention
Volumn concentration for 0.1%, the volumn concentration of ethyl alcohol is 25%.
The preferred embodiment of cell processing is taken off as animal tissue of the present invention, in the step (1), disinfectant with
The volume ratio of animal tissue is 5-10：1, the time of sterilizing is 1-2h, and the temperature of sterilizing is 20-25 DEG C；It is highly preferred that disinfection
The volume ratio of agent and animal tissue is 5：1, the time of sterilizing is 1h, and the temperature of sterilizing is 20 DEG C.
The preferred embodiment of cell processing is taken off as animal tissue of the present invention, in the step (2), cleaning solution with
The volume ratio of animal tissue is 20-40：1；It is highly preferred that the volume ratio of cleaning solution and animal tissue is 30：1.
Compared with prior art, beneficial effects of the present invention are：The present invention provides one kind cell is taken off for animal tissue
The novel agent box of processing, it is easy to operate when carrying out de- cell processing to animal tissue using the kit, it is at low cost, and
To product in cell and DNA remain the bottom of compared with；And de- cell degree is higher, products obtained therefrom eliminates main immunogenic ingredient,
Good biocompatibility, immunogenicity is low, and the preferable regulating cell of energy sticks, migrates, is proliferated and breaks up.
Description of the drawings
Fig. 1 is the HE coloration result figures of Matrigel raw material of the present invention；
Fig. 2 is that the SEM of Matrigel raw material Ultrastructural observation of the present invention schemes；
Fig. 3 is seeded to DPI coloration result figure of the Matrigel raw material after 2 days for the present inventor source skin epithelial cell；
Fig. 4 is that the present inventor source skin epithelial cell is seeded to inverted microscope observation of the Matrigel raw material after 2 days
Result figure；
Fig. 5 is seeded to DPI coloration result figure of the Matrigel raw material after 3 days for the present inventor source skin epithelial cell；
Fig. 6 is that the present inventor source skin epithelial cell is seeded to inverted microscope observation of the Matrigel raw material after 3 days
Result figure；
Fig. 7 is the result figure that Matrigel raw material of the present invention repair diabetic mice full thickness dermal；
Fig. 8 is the HE coloration result figures that Matrigel raw material of the present invention repair diabetic mice full thickness dermal.
Specific embodiment
For the object, technical solutions and advantages of the present invention are better described, below in conjunction with the drawings and specific embodiments pair
The present invention is described further.
Embodiment 1
The present invention takes off a kind of embodiment of the kit of cell processing for animal tissue, and animal is used for described in the present embodiment
The kit of the de- cell processing of tissue includes de-cell liquid A and de-cell liquid B；Solute in the de-cell liquid A is sodium carbonate
With EDTA- trisodiums, in de-cell liquid A, the mass fraction of sodium carbonate is that the mass fraction of 5%, EDTA- trisodiums is 0.1%；；Institute
It states de-cell liquid B to be made of acid solution and salting liquid, in the de-cell liquid B, acid in acid solution is hydrochloric acid, in salting liquid
Salt is sodium chloride；In the de-cell liquid B, the concentration of hydrochloric acid is 1.0mol/L, and the concentration of sodium chloride is 1.0mol/L.
Use kit described in the present embodiment carry out animal tissue take off the method for cell processing for：
(1) surface clean：Chitterlings outer wall fat is wiped out, chitterlings content is washed off with tap water, isolates small
Intestinal mucosa lower floor, is rinsed 3 times using water for injection, then is rinsed with purified water to surface without spot, by the small intestinal mucosa after flushing
Lower-hierarchy material is placed in strainer drainage 5 minutes, and after being filtered dry, the device for taking volume with graduated cylinder equivalent is measured.
(2) sterilize：Intestinal mucosa lower floor is put into the low concentration Peracetic acid-ethyl alcohol prepared equipped with sterile water for injection
In solution disinfection agent, impregnate；In the disinfectant, the volumn concentration of Peracetic acid is 0.1%, and the volume basis of ethyl alcohol contains
It measures as 25%, disinfectant and intestinal mucosa lower volume ratio 10:1, sterilization time 1h, sterilising temp scope are 20 DEG C.
(3) cleaning process：The small intestinal submucosa obtained using cleaning solution cleaning step (2), cleaning solution pH value are 7.3
PBS solution, PBS solution temperature is 20 DEG C, and PBS solution and small intestinal submucosa organization material volume ratio are 30:1, cleaning time
Number 3-5 times, it is 20-30 minutes each；Then cleaned using purified water, the volume ratio of purified water and small intestinal submucosa is 20-40:
1, until detection electrical conductivity terminates for below 10 μ S/cm.
(4) using de-cell liquid A impregnate small intestinal submucosa 12 it is small when, solute in de-cell liquid A for sodium carbonate and
EDTA- trisodiums, in de-cell liquid A, the mass fraction of sodium carbonate is that the mass fraction of 5%, EDTA- trisodiums is 0.1%；；It is de- thin
The pH value of born of the same parents' solution A is 7.3；The volume ratio of de-cell liquid A and small intestinal submucosa is 5:1；It is thin with taking off after cleaning animal tissue
When cytosol B immersions small intestinal submucosa 12 is small, the de-cell liquid B is made of hydrochloric acid solution and salting liquid, the de-cell liquid B
In, the concentration of hydrochloric acid is 1.0mol/L, and the salt in salting liquid is sodium chloride, and the concentration of salt is 1.0mol/L；De-cell liquid B with
The volume ratio of animal tissue is 5:1, the pH value for taking off cell solution B is 7.3.
(5) cleaning process：It is cleaned using cleaning solution, cleaning solution is the PBS solution of pH7.3, and PBS solution temperatures are
20 DEG C, PBS solution and small intestinal submucosa ratio are 30:1, preferably clean 2-5 times, it is 20-30 minutes each；Then 20 are used
DEG C cooling water for injection cleaning, the volume ratio of water for injection and small intestinal submucosa is：20-40:1, detection cleaning injection
The difference for not cleaning with water and water for injection electrical conductivity is terminated less than 1 μ S/cm.
(6) sodium chloride is handled：It is carried out in the constant-temperature ultrasonic washer that can be vibrated in rinse bath, sodium chloride solution is injected
In rinse bath, washer is opened, scavenging period 20min, concentration of sodium chloride solution 0.015mol/L, pH value are no more than
7.8, then with the water for injection cleaning material of flowing, detection electrical conductivity terminates when reaching below 1.5 μ S/cm, clear in the step
Washing trough concussion rate is 200rpm, ultrasonic frequency 45KHZ.
(7) it is fixed-type：It is carried out on mold, the mold is included with pin bottom plate from press box, it is necessary to according to different rule
Small intestinal submucosa host material prepared by step (6) is laid on band pin bottom plate, by institute by the different mold of lattice size selection
It states press box to be positioned on small intestinal submucosa host material, the size of press box can be the size or wider finally cut out, by described in
Band pin bottom plate and the press box are relatively fixed.
(8) small intestinal submucosa host material prepared by step (6) is dispensed into cillin bottle, which needs sterile turn
Fortune and operation.
(9) vacuum freeze drying：It is carried out in vacuum freeze drier, the freeze drying process of product is needed according to difference
Equipment reaffirm, mold is laid in vacuum freeze drier, closes the door of cryodesiccation chamber, opens circulating pump about 1 minute,
Compressor is opened to freeze drying box refrigeration, by the mold of step (7) together with small intestinal submucosa host material above or step
(8) cillin bottle that dispense is together with extremely -50 DEG C of the small intestinal submucosa host material pre-freeze of the inside in, keep the temperature 1-2 it is small when, then
Vacuum pump is opened, -15 DEG C is adjusted the temperature to, when heat preservation 5-7 is small, then adjusts the temperature to 0 DEG C, when heat preservation 2 is small, finally adjust temperature
To 25 DEG C, when heat preservation 4 is small, vacuum freeze drying is completed, and the indoor pressure of chamber of freeze drying plant is 20-25Pa.
(10) pack：After drying material takes out, 3*3cm, 7*7cm, 10* is respectively cut into cutter device on mold
Then 10cm defends strong packaging bag using spy and packs, sealing machine heat-sealing, labelling, which needs sterile transhipment and operation, obtain
Bion surface of a wound host material is Matrigel raw material.After cillin bottle takes out, bottle cap is covered, Cord blood is to get substrate
Film collagen freeze-dried powder.
(11) sterilize：It is sterilized using 60Coradiation, sterilizing dose 25kGy, when sterilizing 6 is small.
Embodiment 2
The present invention takes off a kind of embodiment of the kit of cell processing for animal tissue, and animal is used for described in the present embodiment
The kit of the de- cell processing of tissue includes de-cell liquid A and de-cell liquid B；Solute in the de-cell liquid A is by potassium carbonate
It is formed with EDTA tetrasodium salts；The de-cell liquid B is made of acid solution and salting liquid, in the de-cell liquid B, in acid solution
For acid for Glycolic acid and HCl, the salt in salting liquid is sodium sulphate and potassium sulfate；
In the de-cell liquid A, the mass fraction of solute is 10%；In the de-cell liquid B, sour concentration is
1.0mol/L, the concentration of salt is 1.5mol/L.
Use kit described in the present embodiment carry out animal tissue take off the method for cell processing for：
(1) surface clean：Fresh pericardium is gathered from the ox just butchered, wipes out the adipose tissue sticked, with originally
Water, which washes off, sticks object, isolates pericardium, is rinsed 3 times using water for injection, then is rinsed with purified water to surface without spot,
Pericardial tissue material after flushing is placed in strainer drainage 5 minutes, after being filtered dry, the device amount of progress of volume is taken with graduated cylinder equivalent
It takes.
(2) sterilize：Pericardium is put into the low concentration Peracetic acid-ethanol solution disinfection prepared equipped with sterile water for injection
In agent, impregnate；In the disinfectant, the volumn concentration of Peracetic acid is 0.1%, and the volumn concentration of ethyl alcohol is
25%, disinfectant and intestinal mucosa lower volume ratio 5:1, sterilization time 1h, sterilising temp scope are 20 DEG C.
(3) cleaning process：The pericardial tissue material obtained using cleaning solution cleaning step (2), cleaning solution are that pH value is
7.2 PBS solution, PBS solution temperature are 20 DEG C, PBS solution and the volume ratio 35 of pericardial tissue material:1, wash number 3
It is secondary, 30 minutes every time；Then cleaned using purified water, purified water is 30 with pericardial tissue material proportion:1, until detection conductance
Rate terminates for below 10 μ S/cm.
(4) using de-cell liquid A impregnate pericardial tissue material 12 it is small when, solute in de-cell liquid A for potassium carbonate and
Tetra- sodium of EDTA-, in de-cell liquid A, the mass fraction of solute is 10%；The pH value of de- cell solution A is 7.2；De-cell liquid A
Volume ratio with small intestinal submucosa is 35:1；It is described de- thin when then using de-cell liquid B immersion pericardial tissues material 12 small
Cytosol B is made of glycol acid solution and salting liquid, and in the de-cell liquid B, the concentration of Glycolic acid is 1.0mol/L, in salting liquid
Salt for sodium sulphate and potassium sulfate, the concentration of salt is 1.5mol/L；The volume ratio of de-cell liquid B and animal tissue is 35:1, it takes off
The pH value of cell solution B is 7.3.
(5) cleaning process：It is cleaned using cleaning solution, cleaning solution is the PBS solution of pH7.2, and PBS solution temperatures are
20 DEG C, the ratio of PBS solution and pericardial tissue material is 30:1, it cleans 3 times, every time 25 minutes；Then 20 DEG C of drop is used
The water for injection cleaning of temperature, water for injection are 30 with pericardial tissue material proportion (volume ratio):1, detection cleaning water for injection
And the difference for not cleaning water for injection electrical conductivity is terminated less than 1 μ S/cm.
(6) sodium chloride is handled：It is carried out in the constant-temperature ultrasonic washer that the step can shake in rinse bath, sodium chloride is molten
In liquid injection rinse bath, washer is opened, scavenging period 20min, concentration of sodium chloride solution 0.015mol/L, pH value are not
More than 7.8, then with the water for injection cleaning material of flowing, detection electrical conductivity terminates when reaching below 1.5 μ S/cm.The step
Middle rinse bath concussion rate is 200rpm, ultrasonic frequency 45KHZ.
(7) freeze, cut, sizing：After the completion of above-mentioned cleaning, it is put into after freeze drier freezes, according to clinical different
Indication needs, and acellular dermal matrix is cut respectively and is shaped into：Sheet type, mesh type, circular hole, particle type, are given birth to
Object type surface of a wound host material is Matrigel raw material.
(8) packaging and irradiation sterilization technique：Shaping packaging sterilizes through gamma-ray irradiation.
Embodiment 3
The present invention takes off a kind of embodiment of the kit of cell processing for animal tissue, and animal is used for described in the present embodiment
The kit of the de- cell processing of tissue includes de-cell liquid A and de-cell liquid B；Solute in the de-cell liquid A is by sodium carbonate
It is formed with EDTA tetrasodium salts；The de-cell liquid B is made of acid solution and salting liquid, in the de-cell liquid B, in acid solution
For acid for Glycolic acid and HCl, the salt in salting liquid is sodium sulphate and sodium chloride；
In the de-cell liquid A, the mass fraction of solute is 2~10%；In the de-cell liquid B, sour concentration is
1.0mol/L, the concentration of salt is 1.5mol/L.
Use kit described in the present embodiment carry out animal tissue take off the method for cell processing for：
(1) split-thickness skin graft is prepared：The skin of sheep is cleaned, it is the disconnected of 0.1-0.2mm that sheepskin skin is made thickness with dermatome
Layer skin graft, split-thickness skin graft of different shapes is made with card punch by split-thickness skin graft；
(2) sterilize：Split-thickness skin graft is put into the low concentration Peracetic acid-ethanol solution prepared equipped with sterile water for injection to disappear
In toxic agent, impregnate；In the disinfectant, the volumn concentration of Peracetic acid is 0.15%, and the volumn concentration of ethyl alcohol is
5%, disinfectant and intestinal mucosa lower volume ratio 6:1, sterilization time 1.5h, sterilising temp scope are 22 DEG C.
(3) cleaning process：The split-thickness skin graft obtained using cleaning solution cleaning step (2), cleaning solution are that pH values are 7.3
PBS solution, PBS solution temperature are 20 DEG C, PBS solution and the volume ratio 40 of pericardial tissue material:1, wash number 3 times, often
Secondary 30 minutes；Then cleaned using purified water, purified water is 40 with pericardial tissue material proportion:1, until detection electrical conductivity is 10
Below μ S/cm are terminated.
(4) when using de-cell liquid A immersion split-thickness skin grafts 10 small, the solute in de-cell liquid A is sodium carbonate and EDTA- tetra-
Sodium, in de-cell liquid A, the mass fraction of solute is 5%；The pH values of de- cell solution A are 7.3；De-cell liquid A is sticked with small intestine
The volume ratio of film lower floor is 25:1；When then using de-cell liquid B immersion pericardial tissues material 10 small, the de-cell liquid B is by acid
Solution and salting liquid form, and in the de-cell liquid B, the acid in acid solution is hydrochloric acid and Glycolic acid, and sour concentration is
1.0mol/L, the salt in salting liquid are sodium chloride and sodium sulphate, and the concentration of salt is 1.5mol/L；De-cell liquid B and animal tissue
Volume ratio be 25:1, the pH value for taking off cell solution B is 7.3.
(5) cleaning process：It is cleaned using cleaning solution, cleaning solution is the PBS solution of pH7.2, and PBS solution temperatures are
20 DEG C, the ratio of PBS solution and skin graft organization material is 25:1, it cleans 3 times 20 minutes every time；Then 20 DEG C of cooling is used
Water for injection cleaning, water for injection and skin graft organization material ratio 25:1, detection cleaning water for injection is not with cleaning injection
The difference of water conductivity is terminated less than 1 μ S/cm.
(6) freeze, cut, sizing：Split-thickness skin graft after the completion of step (5) cleaning is put into after freeze drier freezes, root
It is needed according to clinical different indication, acellular dermal matrix is cut respectively and is shaped into：It is sheet type, mesh type, circular hole, micro-
Grain type, obtains bion surface of a wound host material, is Matrigel raw material.
(7) packaging and irradiation sterilization technique：Shaping packaging sterilizes through gamma-ray irradiation.
Embodiment 4
The present invention takes off a kind of embodiment of the kit of cell processing for animal tissue, and animal is used for described in the present embodiment
The kit of the de- cell processing of tissue includes de-cell liquid A and de-cell liquid B；Solute in the de-cell liquid A is by potassium carbonate
It is formed with sodium phosphate；The de-cell liquid B is made of acid solution and salting liquid, and in the de-cell liquid B, the acid in acid solution is
Hydrochloric acid, the salt in salting liquid are potassium chloride and potassium sulfate；
In the de-cell liquid A, the mass fraction of solute is 2%；In the de-cell liquid B, sour concentration is 0.8mol/
L, the concentration of salt is 4mol/L.
Use kit described in the present embodiment carry out animal tissue take off the method for cell processing for：
(1) surface clean：The kidney for the ox just butchered is taken, wipes out the adipose tissue sticked, is washed off with tap water glutinous
Addendum isolates Ren Bovis seu Bubali, is rinsed 3 times using water for injection, then is rinsed with purified water to surface without spot, by the ox after flushing
Renal tissue material is placed in strainer drainage 5 minutes, and after being filtered dry, the device for taking volume with graduated cylinder equivalent is measured.
(2) sterilize：Ren Bovis seu Bubali is put into the low concentration Peracetic acid-ethanol solution disinfection prepared equipped with sterile water for injection
In agent, impregnate；In the disinfectant, the volumn concentration of Peracetic acid is 0.1%, and the volumn concentration of ethyl alcohol is
30%, disinfectant and intestinal mucosa lower volume ratio 8:1, sterilization time 1.5h, sterilising temp scope are 25 DEG C.
(3) cleaning process：The Ren Bovis seu Bubali organization material obtained using cleaning solution cleaning step (2), cleaning solution are that pH value is
7.4 PBS solution, PBS solution temperature are 20 DEG C, PBS solution and the volume ratio 20 of Ren Bovis seu Bubali organization material：1, wash number 3
It is secondary, 30 minutes every time；Then cleaned using purified water, purified water and Ren Bovis seu Bubali organization material ratio are 20:1, until detection conductance
Rate terminates for below 10 μ S/cm.
(4) using de-cell liquid A impregnate Ren Bovis seu Bubali organization material 24 it is small when, solute in de-cell liquid A for potassium carbonate and
Sodium phosphate, in de-cell liquid A, the mass fraction of solute is 2%；The pH value of de- cell solution A is 7.4；De-cell liquid A with it is small
The volume ratio of intestinal mucosa lower floor is 4:1；When then using de-cell liquid B immersion Ren Bovis seu Bubalis organization material 24 small, the de-cell liquid
B is made of hydrochloric acid solution and salting liquid, and in the de-cell liquid B, the concentration of hydrochloric acid is 0.8mol/L, and the salt in salting liquid is chlorine
Change potassium and potassium sulfate, the concentration of salt is 4mol/L；The volume ratio of de-cell liquid B and animal tissue is 4:1, take off cell solution B's
PH values are 7.4.
(5) cleaning process：It is cleaned using cleaning solution, cleaning solution is the PBS solution of pH7.4, and PBS solution temperatures are
20 DEG C, the ratio of PBS solution and Ren Bovis seu Bubali organization material is 20:1, it cleans 3 times, every time 25 minutes；Then 20 DEG C of drop is used
The water for injection cleaning of temperature, water for injection and Ren Bovis seu Bubali organization material ratio (volume ratio) are：20:1, detection cleaning water for injection
And the difference for not cleaning water for injection electrical conductivity is terminated less than 1 μ S/cm.
(6) sodium chloride is handled：It is carried out in the constant-temperature ultrasonic washer that the step can shake in rinse bath, sodium chloride is molten
In liquid injection rinse bath, washer is opened, scavenging period 30min, concentration of sodium chloride solution 2mol/L, pH value are no more than
7.8, then with the water for injection cleaning material of flowing, detection electrical conductivity terminates when reaching below 1.5 μ S/cm.It is clear in the step
Washing trough concussion rate is 100rpm, ultrasonic frequency 80KHZ.
(7) freeze, cut, sizing：After the completion of above-mentioned cleaning, it is put into after freeze drier freezes, according to clinical different
Indication needs, and acellular dermal matrix is cut respectively and is shaped into：Sheet type, mesh type, circular hole, particle type, are given birth to
Object type surface of a wound host material is Matrigel raw material.
(8) packaging and irradiation sterilization technique：Shaping packaging sterilizes through gamma-ray irradiation.
Embodiment 5
The present invention takes off a kind of embodiment of the kit of cell processing for animal tissue, and animal is used for described in the present embodiment
The kit of the de- cell processing of tissue includes de-cell liquid A and de-cell liquid B；Solute in the de-cell liquid A is by potassium carbonate
It is formed with potassium phosphate；The de-cell liquid B is made of acid solution and salting liquid, and in the de-cell liquid B, the acid in acid solution is
Lactic acid, the salt in salting liquid are sodium sulphate and potassium sulfate,
In the de-cell liquid A, the mass fraction of solute is 10%；In the de-cell liquid B, sour concentration is 2mol/
L, the concentration of salt is 0.8mol/L.
Use kit described in the present embodiment carry out animal tissue take off the method for cell processing for：
(1) surface clean：The bladder with the ox just butchered is taken, the adipose tissue sticked is wiped out, is washed with tap water
Except object is sticked, ox bladder is isolated, is rinsed 3 times using water for injection, then is rinsed with purified water to surface without spot, after flushing
Ox bladder body material be placed in strainer drainage 5 minutes, after being filtered dry, the device for taking volume with graduated cylinder equivalent is measured.
(2) sterilize：Ox bladder is put into the low concentration Peracetic acid-ethanol solution disinfection prepared equipped with sterile water for injection
In agent, impregnate；In the disinfectant, the volumn concentration of Peracetic acid is 0.05%, and the volumn concentration of ethyl alcohol is
30%, disinfectant and ox bladder volume ratio 10:1, sterilization time 2h, sterilising temp scope are 25 DEG C.
(3) cleaning process：The ox bladder body material obtained using cleaning solution cleaning step (2), cleaning solution are that pH value is
7.2 PBS solution, PBS solution temperature are 20 DEG C, PBS solution and the volume ratio 40 of ox bladder body material:1, wash number 3
It is secondary, 30 minutes every time；Then cleaned using purified water, purified water is 40 with ox bladder body material proportion:1, until detection conductance
Rate terminates for below 10 μ S/cm.
(4) when using de-cell liquid A immersion ox bladder bodies material 8 small, the solute in de-cell liquid A is potassium carbonate and phosphorus
Sour potassium, in de-cell liquid A, the mass fraction of solute is 10%；The pH value of de- cell solution A is 7.2；De-cell liquid A and ox wing
The volume ratio of Guang is 30:1；When then using de-cell liquid B immersion ox bladder bodies material 8 small, the de-cell liquid B is molten by lactic acid
Liquid and salting liquid composition, in the de-cell liquid B, the concentration of lactic acid is 2.0mol/L, and the salt in salting liquid is sodium sulphate and sulphur
Sour potassium, the concentration of salt is 0.8mol/L；The volume ratio of de-cell liquid B and animal tissue is 30:1, the pH value of de- cell solution B is
7.2。
(5) cleaning process：It is cleaned using cleaning solution, cleaning solution is the PBS solution of pH7.2, and PBS solution temperatures are
20 DEG C, the ratio of PBS solution and ox bladder body material is 30:1, it cleans 3 times, every time 25 minutes；Then 20 DEG C of drop is used
The water for injection cleaning of temperature, water for injection and Ren Bovis seu Bubali organization material ratio (volume ratio) are：30:1, detection cleaning water for injection
And the difference for not cleaning water for injection electrical conductivity is terminated less than 1 μ S/cm.
(6) sodium chloride is handled：It is carried out in the constant-temperature ultrasonic washer that the step can shake in rinse bath, sodium chloride is molten
In liquid injection rinse bath, washer is opened, scavenging period 5min, concentration of sodium chloride solution 2mol/L, pH value are no more than
7.8, then with the water for injection cleaning material of flowing, detection electrical conductivity terminates when reaching below 1.5 μ S/cm.It is clear in the step
Washing trough concussion rate is 300rpm, ultrasonic frequency 20KHZ.
(7) freeze, cut, sizing：After the completion of above-mentioned cleaning, it is put into after freeze drier freezes, according to clinical different
Indication needs, and acellular dermal matrix is cut respectively and is shaped into：Sheet type, mesh type, circular hole, particle type, are given birth to
Object type surface of a wound host material is Matrigel raw material.
(8) packaging and irradiation sterilization technique：Shaping packaging sterilizes through gamma-ray irradiation.
Embodiment 6
The present invention takes off the kit of cell processing and carries out animal tissue using the kit and takes off carefully for animal tissue
A kind of embodiment of the method for born of the same parents' processing, the present embodiment take off the kit of cell processing for animal tissue and use the reagent
Box carries out animal tissue and takes off the method for cell processing and the difference is that only for embodiment 1：In the present embodiment, de-cell liquid A
In solute for tetra- sodium of sodium carbonate and EDTA-, in de-cell liquid A, the mass fraction of sodium carbonate is the quality of 5%, EDTA-, tetra- sodium
Fraction is 0.01%；The pH values of de- cell solution A are 7.3.
Embodiment 7
The present invention takes off the kit of cell processing and carries out animal tissue using the kit and takes off carefully for animal tissue
A kind of embodiment of the method for born of the same parents' processing, the present embodiment take off the kit of cell processing for animal tissue and use the reagent
Box carries out animal tissue and takes off the method for cell processing and the difference is that only for embodiment 1：In the present embodiment, de-cell liquid A
In solute for sodium carbonate and EDTA- trisodiums, in de-cell liquid A, the mass fraction of sodium carbonate is the quality of 5%, EDTA- trisodiums
Fraction is 1%；The pH values of de- cell solution A are 7.3.
Embodiment 8
The present embodiment to the bion surface of a wound host material (i.e. Matrigel raw material) that 1 step of embodiment (10) obtains into
Row physicochemical property, Biological Detection.
1st, physical and chemical performance detection is carried out to the bion surface of a wound host material of preparation, detection project includes appearance, rule
Lattice size.
(1) appearance measures：Appearance white or micro- Huang, free from admixture and foreign matter, meet the requirements.
(2) specification measures：It is detected using the general measurer for meeting required precision, result is the length of XSM-S3
It spends for 3.09-3.20cm, width 3.06-3.16cm；The length of XSM-S7 is 7.20-7.25cm, width 6.95-
7.20cm；The length of XSM-S10 is 10.20-10.25cm, width 10.15-10.20cm.Meet《Bion surface of a wound matrix
Material》Product technology requirement.
2nd, physical and chemical performance detection is carried out to the bion surface of a wound host material of preparation, detection project includes pH values, weight
Metal (in terms of lead) content, protein content, DNA residual quantities, endotoxin residual quantity.
(1) pH value measures：According to GB/T 14233.1《Medical infusion, blood transfusion, instrument used for injection method of inspection first portion：
Chemical analysis method》Method test specified in middle 5.4.1, the results show that the pH value difference of leaching liquor and blank control group is
0.685, meet《Bion surface of a wound host material》1.0 as defined in product technology requirement.
(2) heavy metal (in terms of lead) assay：According to《Pharmacopoeia of People's Republic of China》2015 editions four general rules 0800
0821 the second method of heavy metal inspection technique requirement in limitation inspection technique is measured, the results show that content of beary metal is not more than
10ug/g meets《Bion surface of a wound host material》Product technology requirement.
(3) protein content determination：According to《Pharmacopoeia of People's Republic of China》2015 editions four 0731 protein of general rule contain
The the first method requirement of amount measuring method is measured, the results show that protein content is 85.0%, is met《Bion surface of a wound matrix material
Material》50% is no less than specified in product technology requirement.
(4) the DNA determination of residual amount：With reference to the 25th Some Animals source of YY/T 0606.25-2014 organizational projects medical product
Property biomaterial DNA determination of residual amount methods:Fluorescence colour is measured according to sample itself characteristic design method, as a result shows
Show, DNA residual quantities are 2.34ng/mg, are met《Bion surface of a wound host material》It should not exceed specified in product technology requirement
50ng/mg。
(5) the endotoxin determination of residual amount：According to 6cm2 samples add 1mL extraction medium ratio, 37 ± 1 DEG C, 72 ± 2h systems
Standby experimental liquid, extraction medium are physiological saline.By GB/T 14233.2-2005《Medical infusion, blood transfusion, instrument used for injection inspection party
Method second portion：BiologicalAssays Procedures》Defined method test detects 3 batches of samples.The results show that endotoxin content is less than
5EU/g。
3rd, physical and chemical performance detection is carried out to the bion surface of a wound host material of preparation, detection project includes sterility test
It measures, systemic acute toxi-city measures, cytotoxicity assay, and sensitization test (STT) measures, and genetoxic measures, and Implantation Test measures, skin
Internal stimulus measure.
(1) sterility test measures：According to《Pharmacopoeia of People's Republic of China》Four general rules of 2O15 versions, 1100 biology checks
1101 sterility test law regulations in method carry out, and the results show is sterile, meets《Bion surface of a wound host material》Product technology will
Sterility requirements specified in asking.
(2) systemic acute toxi-city measures：According to GB/T 16886.12-2005 BiologicalEvaluationofMedicalDevices the 12nd
Point：Sample preparation and the requirement of reference sample prepare sample, extract medium as physiological saline and cottonseed oil, the water absorption capacity of sample
For 2ml/0.1g (i.e. 0.1g samples water absorption is 2ml), ratio 3ml/0.1g (i.e. 0.1g samples extract medium with 3ml) is extracted,
Leaching liquor is made when extraction 72 ± 2 is small under the conditions of 37 ± 1 DEG C.It is commented according to GB/T16886.11-2011 medical instrument biology
The 11st part of valency：Prescriptive procedure in general toxicity experiment carries out, the results show that product is reacted without Acute systemic toxicity.
(3) cytotoxicity assay：According to the 12nd part of GB/T 16886.12-2005 BiologicalEvaluationofMedicalDevices：Sample
The requirement that product are prepared with reference sample prepares sample, and extraction medium is serum-containing media, and the water absorption capacity of sample is 2ml/
0.1g (i.e. 0.1g samples water absorption is 2ml), extraction ratio 3ml/0.1g (i.e. 0.1g samples 3ml extractions medium), 37 ±
Leaching liquor is made when extraction 72 ± 2 is small under the conditions of 1 DEG C.According to GB/T16886.5-2003 BiologicalEvaluationofMedicalDevices the 5th
Point：Prescriptive procedure in vitro cytotoxicity test carries out, the results show that cell-cytotoxic reaction is less than 1 grade.
(4) sensitization test (STT) measures：According to the 12nd part of GB/T 16886.12-2005 BiologicalEvaluationofMedicalDevices：Sample
Prepared by product prepares sample with the requirement of reference sample, and extraction medium is physiological saline, the water absorption capacity of sample be 2ml/0.1g (i.e.
0.1g sample water absorptions are 2ml), extraction ratio 3ml/0.1g (i.e. 0.1g samples extract medium with 3ml), in 37 ± 1 DEG C of conditions
It is lower extraction 72 ± 2 it is small when leaching liquor is made.According to the 10th part of GB/T16886.10-2005 BiologicalEvaluationofMedicalDevices：Thorn
Swash and carried out with the prescriptive procedure in delayed allergy experiment, the results show that without delayed allergy.
(5) genetoxic measures：According to the 12nd part of GB/T 16886.12-2005 BiologicalEvaluationofMedicalDevices：Sample
Prepared by product prepares sample with the requirement of reference sample, and extraction medium is physiological saline, the water absorption capacity of sample be 2ml/0.1g (i.e.
0.1g sample water absorptions are 2ml), extraction ratio 3ml/0.1g (i.e. 0.1g samples extract medium with 3ml), in 37 ± 1 DEG C of conditions
It is lower extraction 72 ± 2 it is small when leaching liquor is made.By GB/T16886.3-2008 BiologicalEvaluationofMedicalDevice third portions：Hereditary poison
Property, the prescriptive procedure of carcinogenicity and reproductive toxicity test carry out, the results show that the genetic toxicity test of product is feminine gender.
(6) Implantation Test measures：According to the 6th part of GB/T 16886.6-1997 BiologicalEvaluationofMedicalDevices：Implantation
The prescriptive procedure of local reaction experiment carries out afterwards, the results show that being subcutaneously implanted 1 week：Visible neutrophil cell, leaching around sample
Bar cell and macrophages infiltration, no blister cavities are formed；It is subcutaneously implanted 4 weeks, visible a small amount of macrophage and lymph are thin around sample
Born of the same parents, collagenous fibres and proliferation of fibroblast have fiber blister cavities to be formed；It is subcutaneously implanted 12 weeks：Visible a small amount of lymph around sample
Cell, collagenous fibres, fiber blister cavities are finer and close regular.
(7) intracutaneous stimulate measures：According to the 12nd part of GB/T 16886.12-2005 BiologicalEvaluationofMedicalDevices：Sample
The requirement that product are prepared with reference sample prepares sample, and extraction medium is physiological saline and cottonseed oil, and the water absorption capacity of sample is
2ml/0.1g (i.e. 0.1g samples water absorption is 2ml), extraction ratio 3ml/0.1g (i.e. 0.1g samples extract medium with 3ml),
Leaching liquor is made according to GB/T16886.10-2005 BiologicalEvaluationofMedicalDevices when extraction 72 ± 2 is small under the conditions of 37 ± 1 DEG C
10th part：It stimulates and is carried out with the prescriptive procedure in delayed allergy experiment, the results show that test specimen and solvent control
The difference of mean score is less than 1.0.
4th, histology
(1) optical microphotograph sem observation：Method：Material after paraffin embedding carries out hematoxylin eosin staining, light microscope
Observation.The results show that acellular and cell fragment residual, collagen is micro- continuously without fracture, as shown in Figure 1.
(2) Ultrastructural observation, the results show that material porous structure, micro- no fracture, uniform pore diameter, aperture size
For 100-800 μm, mean pore size is 200 μm.Porosity is more than 85%, as shown in Figure 2.
5th, growth factor detects
According to 6cm2Sample adds the ratio of 1mL extraction media, and 37 ± 1 DEG C, 72 ± 2h prepares experimental liquid, and extraction medium is made a living
Manage brine.Using ELISA method detection leaching liquor neutral and alkali growth factor (bFGF), vascular endothelial growth factor (VEGF), conversion
Growth factor (TGF-β) and tumor necrosis factor (TNF-α) content, the results show that bFGF contents are 5.90 ± 4.01pg/mg,
VEGF contents are 70.14 ± 23.37ng/mg, and TGF-β content is 11.93 ± 4.31pg/mg, TNF-α content for 9.11 ±
5.62pg/mg。
9 chronic wounds reparation of embodiment
1st, people source skin epithelial cell contacts culture with bion surface of a wound host material (i.e. Matrigel raw material)
It is rinsed 2 times with PBS after the people source skin epithelial cell 80% of secondary culture merges, adds in 0.25% trypsase
1ml, observation cellular morphology is rounded under inverted microscope, and the DMEM containing serum is added in when space between cells becomes larger or a small amount of cell takes off wall
Culture solution terminates digestion, collects cell suspension, centrifugation 5min (800min-1), it counts, with 1 × 105The density of/ml is seeded in
Skin epithelial cell layer on bion surface of a wound host material.Before cell inoculation, first by bion surface of a wound host material in PBS
10min is impregnated, then sample is laid in 96 well culture plates, the cell after inoculation is with stent complex in 37 DEG C, 5%CO2
After standing 3h in incubator, appropriate MEM culture solutions are added, continues to put incubator culture, change the liquid once every other day.Culture 3 days
Afterwards, DAPI is dyed, the upgrowth situation of inverted microscope observation cellular morphology and different level.
The results show that cell inoculation finds that cell attaches to stent to inverted microscope observation after acellular matrix 1 day
On material, people source skin epithelial cell visible cell multiplication well-grown after 2 days, gradual fusion figure (see Fig. 3,4).After 3 days
Observer source skin epithelial cell is thin ellipse, is combined closely figure with bion surface of a wound host material rack surface, and
There is cell intrusion internal stent figure (see Fig. 5,6).
2nd, bion surface of a wound host material repairs the experiment of diabetic mice full thickness dermal
Diabetes chronic wound model prepares cleaning grade, with week old rat 60, and 250~300g of weight, Rat Fast is for 24 hours
Afterwards, measure fasting blood-glucose (FBS) normally, be then injected intraperitoneally 1% chain arteries and veins assistant rhzomorph (STZ, citric acid and sodium citrate liquid according to
1:1.32 proportional arrangement buffer solutions, pH=4.3, for stablizing drug) 60 mg/kg, 1 time.FBS is surveyed after 7 days, is then surveyed within every 3 days
It is 1 time fixed.There are more drinks, a diuresis performance, the 7mmol/L of FBS >=16. is judged as the positive, daily to survey FBS 1 time, continues monitoring 1 week, often
Secondary FBS >=16.7mmol/L person is successfully prepared for diabetes model, for this experiment.By diabetes rat back defeathering, in the back of the body
Middle part opens 1cm along by dorsal line both sides and respectively does the circular marks of two diameter 1.5cm, and circular incision is done up to hypodermic layer along mark, complete
It is whole to cut full thickness skin tissue, skin wound is formed, calculates surface of a wound area as Wound evaluation baseline area.
In the 7th, 14,28 day every group randomly select 8 rats take off cervical approach put to death, take 2 mm scopes of the surface of a wound and surface of a wound periphery
Interior full thickness skin sample, clip edge of wound intersection granulation tissue, conventional section, Hematoxylin-eosin (HE) dyeing, Microscopic observation
Granulation tissue generation, newborn collagen arrangement, epithelial layer formation, granulation vascularization and cell infiltration situation.Every mouse
Observe 4-5 sections.
When repairing diabetic mice full thickness dermal using Matrigel raw material of the present invention, the different time points surface of a wound is substantially
The results are shown in Figure 7 for observation, and HE coloration results are as shown in figure 8, Wound healing rate is as shown in table 1.
Table 1
| Group | The 3rd day after treatment | The 7th day after treatment | The 14th day after treatment | The 21st day after treatment | The 28th day after treatment |
| Test group | 12.00±2.69 | 62.00±8.25* | 90.00±2.27* | 100.00±0* | 100.00±0 |
| Control group | 10.00±3.84 | 40.00±7.59 | 78.00±4.38 | 89.00±3.54 | 98.00±2.67 |
Note：Compared with the control group：* P ＜ 0.05
From figure 7 it can be seen that the 3rd day rats in test groups surface of a wound starts to shrink at after wound, hereafter surface of a wound diminution process is very fast,
The 21st day surface of a wound heals substantially after to wound.Control rats are then different, and postoperative 3rd day some individuals surface of a wound increase occur or shrink
Unobvious, and subsequent agglutination is also more slow, until healing substantially after the 28th day after wound.It is two groups big to count each time point
Mouse Wound healing rate, the results are shown in Table 1, and in Each point in time, test group wound healing average area is significantly greater than control group.
As shown in figure 8, the 7th day experimental group institutional framework is more visible, come into existence a small amount of granulation tissue and adenoid structure, right
According to a large amount of inflammatory cell infiltrations of group., there is collagen beam and skin knot in the visible a large amount of fibroblasts of the 14th day test group of experimental group
Structure, organizational hierarchy healing are good, it is seen that and a large amount of angeogenesis, 14 days fibroblast quantity of control group is few compared with experimental group,
There are a small amount of inflammatory cell, institutional framework unobvious.2 groups of surface of a wound heal substantially within 28 days, and cell category is reduced, and there are a large amount of glue
Former beam, capillary increase, and recover epidermal structure substantially.
Embodiment 10
The present embodiment compares when carrying out de- cell to animal tissue using different de-cell liquids, obtained basilar memebrane collagen
The effect of material.The preparation method of the present embodiment Matrigel raw material is：
(1) surface clean：Chitterlings outer wall fat is wiped out, chitterlings content is washed off with tap water, isolates small
Intestinal mucosa lower floor, is rinsed 3 times using water for injection, then is rinsed with purified water to surface without spot, by the small intestinal mucosa after flushing
Lower-hierarchy material is placed in strainer drainage 5 minutes, and after being filtered dry, the device for taking volume with graduated cylinder equivalent is measured.
(2) sterilize：Intestinal mucosa lower floor is put into the low concentration Peracetic acid-ethyl alcohol prepared equipped with sterile water for injection
In solution disinfection agent, impregnate；In the disinfectant, the volumn concentration of Peracetic acid is 0.05-1%, the volume hundred of ethyl alcohol
It is 5-30% to divide content, and disinfectant and intestinal mucosa lower volume compare 5-10：1, sterilization time 1-2h, sterilising temp model
It encloses for 20-25 DEG C.
(3) cleaning process：The small intestinal submucosa obtained using cleaning solution cleaning step (2) is then clear using purified water
It washes, the volume ratio of purified water and small intestinal submucosa is 20-40:1, until detection electrical conductivity terminates for below 10 μ S/cm.
(4) when using de-cell liquid A immersions small intestinal submucosa 8~24 small, the mass fraction of solute is in de-cell liquid A
2~10%；The volume ratio of de-cell liquid A and small intestinal submucosa is 4~30:1；Then small intestinal mucosa is impregnated with de-cell liquid B
When lower floor 8~24 is small, de-cell liquid B is made of acid solution and salting liquid, in the de-cell liquid B, sour concentration for 0.8~
2mol/L, the concentration of salt are 0.8~4mol/L, and the volume ratio of de-cell liquid B and animal tissue is 4~30:1.
(5) cleaning process：It is cleaned, is then cleaned using the water for injection of 20 DEG C of cooling, injection using cleaning solution
Volume ratio with water and small intestinal submucosa is：20-40:1, detection cleaning water for injection and do not clean water for injection electrical conductivity it
Difference is less than 1 μ S/cm and terminates.
(6) it is fixed-type：It is carried out on mold, the mold is included with pin bottom plate from press box, it is necessary to according to different rule
Small intestinal submucosa host material prepared by step (5) is laid on band pin bottom plate, by institute by the different mold of lattice size selection
It states press box to be positioned on small intestinal submucosa host material, the size of press box can be the size or wider finally cut out, by described in
Band pin bottom plate and the press box are relatively fixed.
(7) small intestinal submucosa host material prepared by step (5) is dispensed into cillin bottle, which needs sterile turn
Fortune and operation.
(8) vacuum freeze drying：It is carried out in vacuum freeze drier, the freeze drying process of product is needed according to difference
Equipment reaffirm, mold is laid in vacuum freeze drier, closes the door of cryodesiccation chamber, opens circulating pump about 1 minute,
Compressor is opened to freeze drying box refrigeration, by the mold of step (6) together with small intestinal submucosa host material above or step
(7) cillin bottle that dispense is together with extremely -50 DEG C of the small intestinal submucosa host material pre-freeze of the inside in, keep the temperature 1-2 it is small when, then
Vacuum pump is opened, -15 DEG C is adjusted the temperature to, when heat preservation 5-7 is small, then adjusts the temperature to 0 DEG C, when heat preservation 2 is small, finally adjust temperature
To 25 DEG C, when heat preservation 4 is small, vacuum freeze drying is completed, and the indoor pressure of chamber of freeze drying plant is 20-25Pa.
(9) pack：After drying material takes out, 3*3cm, 7*7cm, 10* is respectively cut into cutter device on mold
Then 10cm defends strong packaging bag using spy and packs, sealing machine heat-sealing, labelling, the process need sterile transhipment and operation to get
Bion surface of a wound host material is Matrigel raw material.After cillin bottle takes out, bottle cap is covered, Cord blood is to get substrate
Film collagen freeze-dried powder.
(10) sterilize：It is sterilized using 60Coradiation, sterilizing dose 25kGy, when sterilizing 6 is small.
Wherein, the composition of de-cell liquid A and de-cell liquid B are as shown in table 2 below, meanwhile, basilar memebrane collagen made from measure
The DNA residual quantities of material and DNA quantity, the results are shown in Table 2.Wherein, the method for DNA residues detections is：It is residual according to biological agent
Stay DNA detection methods《Chinese Pharmacopoeia》Version the 4th in 2015, the sample provided using fluorescence colour detection different tests group
Product DNA residual quantities.DNA quantity uses histology, specifically uses optical microphotograph sem observation：Each test group takes three samples
HE dyeing is carried out respectively, and 3 visuals field are selected in each section, in 400 times of optical microphotograph Microscopic observation intact cell quantity divided by 3, are put down
Each visual field intact cell quantity result should be less than 10.
Table 2
By table 2 as it can be seen that de-cell liquid using the present invention, de- cell effect is preferable, Matrigel raw material obtained
DNA residual quantities are low, and DNA quantity is few.
Finally, it should be noted that the above embodiments are merely illustrative of the technical solutions of the present invention rather than the present invention is protected
The limitation of scope is protected, although being explained in detail with reference to preferred embodiment to the present invention, those of ordinary skill in the art should
Understand, technical scheme can be modified or replaced equivalently, without departing from the essence of technical solution of the present invention
And scope.
Claims (10)
1. a kind of kit that cell processing is taken off for animal tissue, which is characterized in that including de-cell liquid A and de-cell liquid B；
Solute in the de-cell liquid A is sodium carbonate, in potassium carbonate, EDTA trisodiums, tetra- sodium of EDTA, sodium phosphate, potassium phosphate at least
It is a kind of；The de-cell liquid B is made of acid solution and salting liquid, the acid in the acid solution for HCl, phosphoric acid, sulfuric acid, acetic acid,
At least one of lactic acid, Glycolic acid, oxalic acid；Salt in the salting liquid is sodium chloride, in potassium chloride, sodium sulphate, potassium sulfate
At least one.
2. the kit of cell processing is taken off for animal tissue as described in claim 1, which is characterized in that the de-cell liquid
Solute in A is made of (a) sodium carbonate and (b) EDTA trisodiums or tetra- sodium of EDTA；In the de-cell liquid B, the acid in acid solution
For hydrochloric acid, salt in salting liquid is in sodium chloride or the de-cell liquid B, and the acid in acid solution is Glycolic acid and HCl, salt
Salt in solution is sodium sulphate and sodium chloride.
3. such as claim 1~2 any one of them takes off the kit of cell processing for animal tissue, which is characterized in that institute
It states in de-cell liquid A, the mass fraction of solute is 2~10%；In the de-cell liquid B, sour concentration is 0.8~2mol/L,
The concentration of salt is 0.8~4mol/L.
4. the preparation method of Matrigel raw material as claimed in claim 3, which is characterized in that the de-cell liquid A is under
State the component composition of mass percent：(a) sodium carbonate 5% and tetra- sodium 0.01%-1% of (b) EDTA trisodiums or EDTA；It is described de- thin
Cytosol B is made of the component of following concentration：Hydrochloric acid 1mol/L and sodium chloride 1mol/L.
5. application of the kit in cell processing is taken off for animal tissue as described in any one of Claims 1 to 4.
6. application as claimed in claim 5, which is characterized in that the animal tissue is small intestine, nerve, bladder, skin, pericardium
Or kidney；The animal tissue derives from pig, ox or sheep.
7. taking off the method for cell processing using any one of the Claims 1 to 4 kit progress animal tissue, feature exists
In comprising the following steps：
(1) animal tissue is taken, is sterilized after being cleaned；
(2) animal tissue after cleaning step (1) sterilizing, then de- cell processing is carried out to animal tissue using de-cell liquid A；
(3) animal tissue obtained after cell processing is taken off to step (2) using de-cell liquid B and carries out de- cell processing；
(4) step (3) is taken off cell processing gained animal tissue to be placed in PBS buffer solution or water for injection, is started the cleaning processing；
(5) step (4) cleaned animal tissue is freezed and shaped, obtain Matrigel raw material.
8. the method that animal tissue as claimed in claim 7 takes off cell processing, which is characterized in that in the step (2), take off thin
The volume ratio of cytosol A and animal tissue is 4~30:1, using de-cell liquid A impregnate animal tissue 8~24 it is small when；The step
(3) in, the volume ratio of de-cell liquid B and animal tissue is 4~30:1, it is small that animal tissue 8~24 is impregnated using de-cell liquid B
When.
9. the method that animal tissue as claimed in claim 7 takes off cell processing, which is characterized in that the animal tissue is small
Intestines, nerve, bladder, skin, pericardium or kidney；The animal tissue derives from pig, ox or sheep.
10. the method that animal tissue as claimed in claim 7 takes off cell processing, which is characterized in that in the step (1), adopt
It is sterilized with disinfectant, the disinfectant contains Peracetic acid, hydrogen peroxide or ethanol solution；In the disinfectant, peroxide
The volumn concentration of acetic acid is 0.05-1%, and the volumn concentration of hydrogen peroxide is 0.5-10%, the volume basis of ethyl alcohol
Content is 5-30%；In the step (2), cleaned using cleaning solution, the cleaning solution be PBS solution or water for injection,
The pH value of the PBS solution is 7.0-7.4.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711409636.1A CN108079363A (en) | 2017-12-19 | 2017-12-19 | A kind of kit and its application that cell processing is taken off for animal tissue |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711409636.1A CN108079363A (en) | 2017-12-19 | 2017-12-19 | A kind of kit and its application that cell processing is taken off for animal tissue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108079363A true CN108079363A (en) | 2018-05-29 |
Family
ID=62178165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711409636.1A Pending CN108079363A (en) | 2017-12-19 | 2017-12-19 | A kind of kit and its application that cell processing is taken off for animal tissue |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108079363A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109946449A (en) * | 2019-03-29 | 2019-06-28 | 南通大学附属医院 | A kind of preparation method of tissue specificity invasion kit |
| CN112618796A (en) * | 2020-11-16 | 2021-04-09 | 北京奥精医疗器械有限责任公司 | Acellular dermal matrix material and preparation method and application thereof |
| CN114304181A (en) * | 2021-12-30 | 2022-04-12 | 苏州昊本生物科技有限公司 | Sterilizing agent and sterilizing method using same |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008097885A2 (en) * | 2007-02-02 | 2008-08-14 | Manh-Dan Ngo | Decellularization of soft tissue |
| EP2229191B1 (en) * | 2007-12-19 | 2012-01-25 | Ethicon, Inc. | Decellularized omentum matrix and uses thereof |
| CN102462561A (en) * | 2010-11-19 | 2012-05-23 | 北京迈迪顶峰医疗科技有限公司 | Small intestinal submucosa (SIS) soft tissue repair patch and preparation method thereof |
| CN202283366U (en) * | 2010-11-19 | 2012-06-27 | 北京迈迪顶峰医疗科技有限公司 | Small intestinal submucosa (SIS) soft tissue recovery patch |
| CN102727935A (en) * | 2012-07-19 | 2012-10-17 | 陕西博鸿生物科技有限公司 | Preparation method and device of duramater/spinal dural transplanting substitute |
| CN103436489A (en) * | 2013-08-30 | 2013-12-11 | 重庆大清医诚生物技术有限公司 | Reagent for acellular processing of animal skin tissue, and processing method thereof |
| CN106492285A (en) * | 2016-10-31 | 2017-03-15 | 广州昕生医学材料有限公司 | Injectable Acellular cartilaginous matrix particulate and its application in implant |
| CN106880872A (en) * | 2016-12-23 | 2017-06-23 | 北京大清生物技术股份有限公司 | Natural extracellular matrix biomembrane and preparation method and application |
-
2017
- 2017-12-19 CN CN201711409636.1A patent/CN108079363A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008097885A2 (en) * | 2007-02-02 | 2008-08-14 | Manh-Dan Ngo | Decellularization of soft tissue |
| EP2229191B1 (en) * | 2007-12-19 | 2012-01-25 | Ethicon, Inc. | Decellularized omentum matrix and uses thereof |
| CN102462561A (en) * | 2010-11-19 | 2012-05-23 | 北京迈迪顶峰医疗科技有限公司 | Small intestinal submucosa (SIS) soft tissue repair patch and preparation method thereof |
| CN202283366U (en) * | 2010-11-19 | 2012-06-27 | 北京迈迪顶峰医疗科技有限公司 | Small intestinal submucosa (SIS) soft tissue recovery patch |
| CN102727935A (en) * | 2012-07-19 | 2012-10-17 | 陕西博鸿生物科技有限公司 | Preparation method and device of duramater/spinal dural transplanting substitute |
| CN103436489A (en) * | 2013-08-30 | 2013-12-11 | 重庆大清医诚生物技术有限公司 | Reagent for acellular processing of animal skin tissue, and processing method thereof |
| CN106492285A (en) * | 2016-10-31 | 2017-03-15 | 广州昕生医学材料有限公司 | Injectable Acellular cartilaginous matrix particulate and its application in implant |
| CN106880872A (en) * | 2016-12-23 | 2017-06-23 | 北京大清生物技术股份有限公司 | Natural extracellular matrix biomembrane and preparation method and application |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109946449A (en) * | 2019-03-29 | 2019-06-28 | 南通大学附属医院 | A kind of preparation method of tissue specificity invasion kit |
| CN112618796A (en) * | 2020-11-16 | 2021-04-09 | 北京奥精医疗器械有限责任公司 | Acellular dermal matrix material and preparation method and application thereof |
| CN112618796B (en) * | 2020-11-16 | 2022-12-09 | 北京奥精医疗器械有限责任公司 | Acellular dermal matrix material and preparation method and application thereof |
| CN114304181A (en) * | 2021-12-30 | 2022-04-12 | 苏州昊本生物科技有限公司 | Sterilizing agent and sterilizing method using same |
| CN114304181B (en) * | 2021-12-30 | 2023-04-21 | 苏州昊本生物科技有限公司 | Sterilizing agent and sterilizing method using same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9642937B2 (en) | Preparation method for implantable medical biological materials of animal origin | |
| CN107007886B (en) | A kind of biological tissue's host material, preparation method and its usage | |
| CN104055795B (en) | A kind of injectable implant and preparation method thereof | |
| CN108699522A (en) | Vessel extracellular matrix hydrogel | |
| CN106456837A (en) | Methods for preparation of a terminally sterilized hydrogel derived from extracellular matrix | |
| CN106190949A (en) | A kind of dry state animal derived collagenous tissue material and preparation method thereof and bioprosthesis | |
| CN106492285A (en) | Injectable Acellular cartilaginous matrix particulate and its application in implant | |
| CN103079577A (en) | Process,tube and device for the preparation of wound healant composition | |
| CN103272274B (en) | Biological repair tablet for herniae and preparation method thereof | |
| CN105999359B (en) | A kind of external application dressing and its preparation method and application | |
| CN106492288A (en) | Injectable de- cellular fat matrix particles and its application in implant | |
| CN108079363A (en) | A kind of kit and its application that cell processing is taken off for animal tissue | |
| CN107397972A (en) | A kind of preparation method of animal skin acellular matrix dressing and the dressing of gained | |
| CN107233621A (en) | Natural soft tissue goes the preparation method of cellular matrix | |
| CN107823710A (en) | A kind of cell epimatrix material of high bioactivity and its preparation method and application | |
| CN107260639A (en) | A kind of gel rich in autologous growth factor repairs facial mask and preparation method thereof | |
| CN111084900A (en) | Preparation method and application of acellular fish skin matrix | |
| EP1333870A2 (en) | Method of preparing and processing transplant tissue | |
| CN108030914A (en) | A kind of Matrigel raw material and preparation method and application | |
| CN103007350A (en) | Modified rat accellular spinal cord bracket material and preparation method thereof | |
| CN103272275B (en) | Biological repair tablet for endocranium and preparation method thereof | |
| CN103301507B (en) | Artificial biological tendon and preparation method thereof | |
| CN103272276B (en) | Anal fistula suppository and preparation method thereof | |
| CN108853571A (en) | A kind of collagen protein sponge and its preparation process | |
| CN102755665A (en) | Preparation method of heterogeneous bone transplantation material |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180529 |
|
| RJ01 | Rejection of invention patent application after publication |